Formulate
active substances into stable products, using robust, validated, and industrializable processes
A 360° development offering
From your initial formulation trials to the production of clinical and small commercial batches, Unither Pharmaceuticals supports you at every step to accelerate the market launch of your medicines and medical devices.
Our development teams work closely with clients and partners to:
Develop
and validate reproducible and easily transferable analytical methods
Produce
preclinical and clinical batches (Phases I to III)
Ensure
regulatory compliance at every stage
Anticipate
the transition to commercial manufacturing at one of our Unither sites or with an industrial partner of the client's choice
Innovative technologies and diversified dosage forms
Sterile liquids
|
Non-sterile liquids
|
Solid forms
|
|---|---|---|
|
Solution |
Solution |
Powder/Granule |
|
Syrop |
Suspension |
Minitablet |
|
Suspension |
Gel |
Uncoated and coated tablet |
|
Emulsion |
Emulsion |
Modified realease tablet |
|
Cream |
Nano-émulsion |
Effervescent tablet |
|
Pomade |
Dispersible and orodispersible tablet |
|
|
Lotion |
Mucoadhesive tablet |
|
|
Multilayer tablet |
||
|
Hard capsule (powder or granule) |
Our added value
- Agile development from active ingredients to commercial products
- Flexibility in the production of small batches for orphan drugs, clinical studies, etc.
- Reduced risks and lead times through a structured approach
- Integrated global network ensuring market proximity in accordance with regulatory standards
Pharmaceutical development expertise
Ophthalmic specialization
Spécialisation ophtalmique
As a recognized specialist in ophthalmic development, Unither Pharmaceuticals supports start-ups, biotechs, and laboratories in designing and producing sterile formulations for the most demanding ocular projects.
Why trust us?
+30 years of experience in pharmaceutical development
Numerous successful development projects each year
Several hundred clinical batches produced
Multi-form and multi-technology expertise
Expert, committed, and innovative teams
Anaïs CASTEX
Business Development Manager – Ophthalmology Early Stage
Anne-Sophie MARIN
Business Development Manager (Bordeaux)
FAQ - Pharmaceutical development
Do you offer the development and production of small batches of veterinary medicines?
Yes. Our Bordeaux site has the necessary expertise and certifications for the development and production of clinical and commercial batches for veterinary medicines.
Can we outsource only the development phase and carry out production elsewhere?
Yes. Unither Pharmaceuticals can work with you on the development phases only, with no obligation to manufacture your product at our sites.
Some products that are developed do not suit our industrial capacities (pharmaceutical forms or specific processes).
In such cases, we help you transfer to the production site of your choice, with methods and formulations designed for ease of transfer.
However, when the product is compatible with our technologies, production at Unither Pharmaceuticals is the most convenient option, particularly in terms of scale-up, risk reduction, and shortening lead times.
Can we outsource only part of the development?
Yes. Our services are modular: formulation, analytics, clinical manufacturing, regulatory support.
Are your analytical methods transferable?
Yes. All our methods are systematically developed with a view to transferring to industrial sites.
As a CDMO, we take industrial requirements into account from the start to ensure smooth, reproducible, and compliant implementation during industrialization.